A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...

CareDx (NASDAQ:CDNA) used an investor webcast to outline its “Transplant Plus” expansion into cell therapy and to highlight ...

A demonstrated 100% concordance between biomarker-guided predictions from pre-treatment patient samples and clinical outcomes ...

The successful clinical validation of AlloHeme represents a key milestone in CareDx's Transplant+ strategy, expanding the Company's precision medicine capabilities into cell therapy, hematology, and ...

An observational study recently published in Cancer highlights a notable correlation between glucose-6-phosphate dehydrogenase (G6PD) deficiency and improved clinical outcomes among patients with ...

Leukaemia is the most common cancer in children worldwide. However, early diagnosis has made survival rates more hopeful than ...

Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer's survival. If one component of the complex is ...

Ivan Stefanov, CEO and Co-Founder of NOTO, shares how AI, machine learning and unified platforms are reshaping financial crime prevention for institutions ...

The UEX Security Standard defines five core benchmarks for the next generation of exchange security: verifiable solvency, ...

Broeden Morss was diagnosed with high-risk acute myeloid leukemia this past December after his mother, Kerynn, noticed he ...

Bitget, the world’s largest Universal Exchange (UEX), today announced the release of The UEX Security Standard: From Proof to ...